Videssa® Breast: Cancer Blood Test
Designed specifically for the early detection of breast cancer in women with abnormal imaging findings
A simple blood test to detect breast cancer with high accuracy in women with abnormal imaging findings
A protein-based blood test combining Serum protein biomarkers (SPBs) with Tumor Associated Autoantibodies (TAAbs).
Previously CLIA certified
Launch as an LDT in USA
Latest Clinical Data
Todos Medical has collected over 1,000 clinical samples in several clinical trials for breast and other cancers conducted at the Wolfson Medical Center (Holon, Israel), Rabin Medical Center (Petach Tikva, Israel), Ichilov Medicalcenter (Tel Aviv, Israel) and in the Ukraine.
The latest clinical trial for Todos Medical’s breast cancer test included 59 patients and achieved 93% sensitivity and 87% specificity, as compared to routine mammography screening.
Todos Breast Screens (TM-B1, TM-B2)
Our breast cancer blood test targets a large population of women who need to be checked regularly for breast cancer, whether that is because they are in a high-risk group or in an age group that should be routinely screened. It is recommended that all women over 40 undergo breast screening. The recommended testing protocols using mammography and ultrasound have limitations and discomfort.
Our proprietary TM-B1 cancer test will support current cancer diagnostic protocols at their weak points (like dense breast tissue in young women) and provide a simple and low-cost solution for early detection.
Our proprietary TM-B2 cancer screen will allow health care providers to distinguish between benign and malignant breast tumors.
women undergo mammography annually in the United States
women undergoing mammography
have dense breasts
have passed legislation that patients be informed of their breast density
The TBIA Platform
Platform for screening of all cancers, starting with Breast Screens (TM-B1, TM-B2) and Colon Screen (TM-C1)
The Total Biochemical Infrared Analysis (TBIA) platform is a proprietary process for screening of solid tumors using peripheral blood spectroscopy analysis.